Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0086132|depressive symptoms
Sentences 18
PubMedID- 20130979 This study investigates whether concerns about reproduction after breast cancer treatment were associated with long-term depressive symptoms.
PubMedID- 22060256 depressive symptoms and health-related quality of life in breast cancer survivors.
PubMedID- 24000126 Risk factors associated with increased depressive symptoms among latinas diagnosed with breast cancer within 5 years of survivorship.
PubMedID- 20183737 This study assessed whether high hypnotizability is associated with posttraumatic stress and depressive symptoms in a sample of 124 metastatic breast cancer patients.
PubMedID- 24726621 Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancer.
PubMedID- 24038706 Objective: this study aimed to determine the effects of cognitive emotion regulation strategies on depressive symptoms in women with breast cancer.
PubMedID- 24804879 Association of the physiological stress response with depressive symptoms in patients with breast cancer.
PubMedID- 20591791 Learned resourcefulness, quality of life, and depressive symptoms for patients with breast cancer.
PubMedID- 23132125 Predictors of initial levels and trajectories of depressive symptoms in women with breast cancer undergoing radiation therapy.
PubMedID- 24756186 Melatonin significantly reduced the risk of depressive symptoms in women with breast cancer during a three-month period after surgery.
PubMedID- 22818228 Objective: this study examined whether the changes in sleep problems, attachment styles, meaning in life, and salivary cortisol over the course of 14 months were the predictors of changes in depressive symptoms in women with breast cancer at post-treatment stage.
PubMedID- 23623178 Social support as a moderator between depressive symptoms and quality of life outcomes of breast cancer survivors.
PubMedID- 26497200 Various factors are related to depressive symptoms in patients with breast cancer, including demographics, disease-related factors, and individual psychosocial characteristics such as coping styles and personality traits .
PubMedID- 25645194 The purposes of this study were: to determine the prevalence of depressive symptoms among women with breast cancer; and examine the association of depressive symptoms and demographic and clinical variables as well as the association between mental adjustment to cancer and level of depressive symptoms.
PubMedID- 23766649 Recently, the evidence suggests that the anxiety trait is a significant determinant of depressive symptoms in patients with breast cancer.31 the recent study of patients with pain symptoms also suggests that anxiety and depression may correlate positively.32 in addition, the significant relationship between them has been reported in the advanced cancer patients with median age of 59 years (range 20–91 years).33 like the present findings, the relationship between both anxiety and depression in sle patients was also noted in the previous study.34 thus, all patients with chronic medical illness, including sle patients, should be also evaluated for depression and anxiety.
PubMedID- 22140397 The symptom cluster of sleep, fatigue and depressive symptoms in breast cancer patients: severity of the problem and treatment options.
PubMedID- 21718146 Trust in physician in relation to blame, regret, and depressive symptoms among women with a breast cancer experience.
PubMedID- 22142651 Escitalopram may be an effective treatment of depressive symptoms in breast cancer patients.

Page: 1